Chang et al., 2015 - Google Patents
Innate immunity drives the initiation of a murine model of primary biliary cirrhosisChang et al., 2015
View HTML- Document ID
- 10612396338110166538
- Author
- Chang C
- Chen Y
- Zhang W
- Leung P
- Gershwin M
- Chuang Y
- Publication year
- Publication venue
- PloS one
External Links
Snippet
Invariant natural killer T (iNKT) cells play complex roles in bridging innate and adaptive immunity by engaging with glycolipid antigens presented by CD1d. Our earlier work suggested that iNKT cells were involved in the initiation of the original loss of tolerance in …
- 206010004661 Biliary cirrhosis primary 0 title abstract description 30
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chang et al. | Innate immunity drives the initiation of a murine model of primary biliary cirrhosis | |
Moro et al. | Bullous pemphigoid: trigger and predisposing factors | |
Dehner et al. | The microbiome in systemic autoimmune disease: mechanistic insights from recent studies | |
Bassani et al. | Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects | |
Zufferey et al. | Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP) | |
Klocke et al. | Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood | |
Wing et al. | Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4 | |
Bende et al. | Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas | |
Bilate et al. | Induced CD4+ Foxp3+ regulatory T cells in immune tolerance | |
Meyer et al. | Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells | |
Berer et al. | Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination | |
Cnops et al. | NK-, NKT-and CD8-derived IFNγ drives myeloid cell activation and erythrophagocytosis, resulting in trypanosomosis-associated acute anemia | |
Enoksson et al. | The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells | |
Honjo et al. | Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR) | |
Park et al. | PPARγ negatively regulates T cell activation to prevent follicular helper T cells and germinal center formation | |
Aschermann et al. | B cells are critical for autoimmune pathology in Scurfy mice | |
Oh et al. | CD4+ CD25+ regulatory T cells in autoimmune arthritis | |
Jha et al. | Lymphocyte activation gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity | |
Ambrosini et al. | The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I: C) and murine autoimmune cholangitis | |
Rui et al. | Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response | |
Wang et al. | Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | |
Hase et al. | Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease | |
Huard et al. | Selective APRIL blockade delays systemic lupus erythematosus in mouse | |
Felton et al. | Anti-insulin B cells are poised for antigen presentation in type 1 diabetes | |
Bieber et al. | Animal models for autoimmune bullous dermatoses |